Imaginot has developed a methodology for prospective partner companies to evaluate the suitability of their drug candidate for application of its
technology.
This paper provides a checklist for companies to assess their drug.
For more info.
Imaginot also has completed feasibility studies on a number of drugs. These studies can be accessed -
Axomadol
Dabigatran
Diclofenac
Eszopiclone
ibuprofen
Ketamine
Montelukast Sodium
Nalmefene
Naproxen
Oxymorphone
Prednisolone
RhuDex
Roflumilast
Suvorexant
Temazepam